Today's Research Reports on Trending Tickers: Puma Biotechnology Inc. and Novavax Inc.

[End Subhead]
[Start Distributor]
Accesswire 18-Jul-2017 8:00 AM
[End Distributor]
NEW YORK, NY / ACCESSWIRE / July 18, 2017 / U.S. markets were relatively quiet Monday as investors eagerly await the latest batch of corporate earnings. Bank of America Corp., General Electric Co., Goldman Sachs Group Inc. and Microsoft Corp. are among the 68 S&P 500 companies scheduled to report earnings this week, according to FactSet. The Dow Jones Industrial Average declined 0.03 percent to close at 21,630.68, while the S&P 500 Index dipped 0.01 percent to close at 2,459.14. The NASDAQ Composite Index gained 0.02 percent to close at 6,314.43. Analysts forecast earnings for S&P 500 companies to increase by approximately 8.2 percent in the second quarter, according to data from Thomson Reuters.
"After new highs that we saw last week, the market deserves a rest as investors await big earnings this week," said Dave Donabedian, Chief Investment Officer of CIBC Atlantic Trust Private Wealth Management. "Our view is that right now the equity market is a one-legged stool that's driven by earnings and we're pretty optimistic about earnings but if that should falter, the market will falter."
RDI Initiates Coverage on:
Puma Biotechnology Inc. https://ub.rdinvesting.com/news/?ticker=PBYI
Novavax Inc. https://ub.rdinvesting.com/news/?ticker=NVAX
Puma Biotechnology Inc.'s stock moved 3.85% lower Monday, to close the day at $86.10. The stock recorded a trading volume of 876,706 shares, which was below its three months average volume of 1,633,350 shares. In the last year, Puma Biotechnology Inc.'s shares have traded in a range of 28.35 - 94.70. The share price has gained 203.70% from its 52 week low. The company's shares are currently trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $70.29 is greater than its 200-day moving average of $44.73. Shares of Puma Biotechnology Inc. have gained approximately 180.46 percent year-to-date.
Access RDI's Puma Biotechnology Inc. Research Report at: https://ub.rdinvesting.com/news/?ticker=PBYI
On Monday, shares in Novavax Inc. recorded a trading volume of 2,943,442 shares, which was below the three months average volume of 6,415,720 shares. The stock ended the day 2.56% lower at 1.14. The share price has gained 56.16% from its 52 week low with a 52 week trading range of 0.73 - 8.49.The company's shares are currently trading below their 200-day moving average. Moreover, the stock's 50-day moving average of $1.06 is below its 200-day moving average of $1.19. Shares of Novavax Inc. have fallen approximately 9.52 percent year-to-date.
Access RDI's Novavax Inc. Research Report at: https://ub.rdinvesting.com/news/?ticker=NVAX
Our Actionable Research on Puma Biotechnology Inc. (NASDAQ: PBYI) and Novavax Inc. (NASDAQ: NVAX) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Nadia Noorani, CFA charter holder. RDInvesting.com is neither a registered broker dealer or a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
contact@rdinvesting.com
CFA and Chartered Financial Analyst are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com